Tryptan: no association with eosinophilia-myalgia syndrome.
Nickel
A
A
D002170:Canada; D004345:Drug Industry; D004802:Eosinophilia / Q000139:chemically induced*; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced*; D013577:Syndrome; D014364:Tryptophan / Q000009:adverse effects*
D014364:Tryptophan